Abstract
CLINICAL and experimental studies suggest that angiogenesis is a prerequisite for solid tumour growth1,2. Several growth factors with mitogenic or chemotactic activity for endothelial cells in vitro have been described, but it is not known whether these mediate tumour vascularization in vivo3,4. Glioblastoma, the most common and most malignant brain tumour in humans, is distinguished from astrocytoma by the presence of necroses and vascular prolifer-ations5'6. Here we show that expression of an endothelial cell-specific mitogen, vascular endothelial growth factor (VEGF), is induced in astrocytoma cells but is dramatically upregulated in two apparently different subsets of glioblastoma cells. The high-affinity tyrosine kinase receptor for VEGF, flt, although not expressed in normal brain endothelium, is upregulated in tumour endothelial cells in vivo. These observations strongly support the concept that tumour angiogenesis is regulated by paracrine mechanisms and identify VEGF as a potential tumour angiogenesis factor in vivo.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach
Cancer Imaging Open Access 12 February 2021
-
Mathematical simulation of tumour angiogenesis: angiopoietin balance is a key factor in vessel growth and regression
Scientific Reports Open Access 11 January 2021
-
Enhanced sensitivity of VEGF detection using catalase-mediated chemiluminescence immunoassay based on CdTe QD/H2O2 system
Journal of Nanobiotechnology Open Access 17 June 2020
Access options
Subscribe to this journal
Receive 51 print issues and online access
204,58 € per year
only 4,01 € per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Weidner, N., Semple, J. P., Welch, W. R. & Folkman, J. New Engl. J. Med. 324, 1–8 (1991).
Folkman, J. J. natn. Cancer Inst. 82, 4–6 (1990).
Folkman, J. & Klagsbrun, M. Science 235, 442–447 (1987).
Risau, W. Progress in Growth Factor Research 2, 71–79 (1990).
Russel, D. C. & Rubinstein, L. J. Pathology of Tumours of the Nervous System 5th edn (Arnold, London, 1989).
Germano, I. M. et al. J. Neurosurg. 70, 701–706 (1989).
Folkman, J. & Shing, Y. J. biol. Chem. 267, 10931–10934 (1992).
Klagsbrun, M. & Folkman, J. Handbook of Experimental Pharmacology Vol. 95/II, 549–586 (Springer. Berlin, 1990).
Bouck, N. Cancer Cells 2, 179–185 (1990).
Folkman, J., Watson, K., Ingber, D. & Hanahan, D. Nature 339, 58–61 (1989).
Liotta, L. A., Steeg, P. S. & Stetler-Stevensohn, W. G. Cell 64, 327–336 (1991).
Plate, K. H., Breier, G., Farrell, C. & Risau, W. Lab. Invest. 67, 529–534 (1992).
Risau, W. et al. Growth Factors (in the press).
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J. & Leung, D. W. J. cell. Biochem. 47, 211–218 (1991).
Breier, G., Albrecht, U., Sterrer, S. & Risau, W. Development 114, 521–532 (1992).
Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F. & Senger, D. R. Molec. Biol. Cell 3, 211–220 (1992).
Conn, G. et al. Proc. natn. Acad. Sci. U.S.A. 87, 1323–1327 (1990).
Weindel, K., Marmé, D. & Weich, H. Biochem. biophys. Res. Commun. 183, 1167–1174 (1992).
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V. & Ferrara, N. Science 246, 1306–1309 (1989).
Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A. & Ferrara, N. J. clin. Invest. 89, 244–253 (1992).
Burger, P. & Green, S. Cancer 59, 1617–1625 (1987).
Ingber, D. et al. Nature 348, 555–557 (1990).
Folkman, J. in Biological Therapy of Cancer (eds Devita, V. T., Hellman, S. & Rosenberg, S. A.) 743–753 (Lippincott, Philadelphia, 1991).
Brem, S. B. et al. Am. J. Path. 137, 1121–1142 (1990).
De Vries, C. et al. Science 255, 989–991 (1992).
Dvorak, H. F. et al. J. exp. Med. 174, 1275–1278 (1991).
Jain, R. K. Cancer Res. 48, 2641–2658 (1988).
Sidransky, D. et al. Nature 355, 846–847 (1992).
Kern, S. E. et al. Science 256, 827–830 (1992).
Scherer, H.-J. Virchows Arch. 294, 823–861 (1935).
Shibuya, M. et al. Oncogene 5, 519–524 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Plate, K., Breier, G., Weich, H. et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845–848 (1992). https://doi.org/10.1038/359845a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/359845a0
This article is cited by
-
Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer
Drug Delivery and Translational Research (2023)
-
From seed to flower: blossoming of microglia in development and brain repair
Cell and Tissue Research (2022)
-
Targeting Angiogenic Factors for the Treatment of Medulloblastoma
Current Treatment Options in Oncology (2022)
-
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach
Cancer Imaging (2021)
-
Mathematical simulation of tumour angiogenesis: angiopoietin balance is a key factor in vessel growth and regression
Scientific Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.